Life Sciences Revance Closes on $300 Million Note Purchase Agreement with Athyrium Capital Management AIT News Desk Mar 21, 2022 - $300 million note purchase agreement includes committed borrowings of $200 million and an additional option of uncommitted borrowings of up to $100…